Buy Like Buffett
Watchlist

Flagship explainer

How TG THERAPEUTICS, INC. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$616M · 100%Cost of revenue$101M · 16%Gross profit$516M · 84%Operating income$123M · 20%Income before tax$107M · 17%Income tax−$340M · −55%Net income$447M · 73%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$616M100%
  • 10-K · FY 2025Filing detailsAccession 0001437749-26-006133 · filed Feb 27, 2026
Cost of revenue$101M16%
  • 10-K · FY 2025Filing detailsAccession 0001437749-26-006133 · filed Feb 27, 2026
$516M84%
  • 10-K · FY 2025Filing detailsAccession 0001437749-26-006133 · filed Feb 27, 2026
$123M20%
  • 10-K · FY 2025Filing detailsAccession 0001437749-26-006133 · filed Feb 27, 2026
Income before tax$107M17%
  • 10-K · FY 2025Filing detailsAccession 0001437749-26-006133 · filed Feb 27, 2026
Income tax−$340M−55%
  • 10-K · FY 2025Filing detailsAccession 0001437749-26-006133 · filed Feb 27, 2026
$447M73%
  • 10-K · FY 2025Filing detailsAccession 0001437749-26-006133 · filed Feb 27, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001437749-26-006133 · filed Feb 27, 2026
· event Dec 31, 2025 · retrieved Oct 24, 2026 · annual-row source set
Embed this chart

View the full TG THERAPEUTICS, INC. analysis at Buy Like Buffett